Abstract
Background: Selective serotonin reuptake inhibitors (SSRI) are commonly used for the treatment of depression and anxiety. Inhibition of serotonin reuptake in platelets increases bleeding risk in patients taking SSRIs. Case: Here, we present the case of a 52-year-old patient who developed severe postsurgical bleeding requiring blood transfusion following panniculectomy. Conclusion: SSRI-induced bleeding is dose-related and strongly influenced by individual variations in drug metabolizing enzymes and transporters. Video abstract: BJYwPVEYn-uvqVov7uRYgK Supplementary file1 (MP4 8441 KB).
Original language | English (US) |
---|---|
Journal | Drugs in R and D |
DOIs | |
State | Accepted/In press - 2024 |
ASJC Scopus subject areas
- Pharmacology